Details for 2020753562

Up to date per 01.04.2026

Actions

Title / Product Name

POLYMORPHE DES (R)-N-(5-(5-ETHYL-1,2,4-OXADIAZOL-3-YL)-2,3-DIHYDRO-1H-INDEN-1-YL)-1-METHYL-1H-PYRAZOL-4-CARBOXAMIDS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020753562

EP Publication Number

3999180

E-Number

1684519

Language

PCT Number

US20042387

Publication Date

25.05.2022 A

08.05.2024 B1

Registration Date

08.05.2024

AT Publication Date

15.05.2024

Application Date

16.07.2020

Registration Number

Priorities

17.07.2019

201962875350 P

IPC

A61P 9/04 20060101AFI20210122BHEP

Maximum Duration of Protection

16.07.2040

Owner

Cytokinetics, Inc.350 Oyster Point Blvd South San Francisco CA 94080US

Representative

SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT

Inventor

TOM, Norma3913 Christian Drive Belmont, California 94002US

PFEIFFER, Matthew567 E. 6th Avenue Salt Lake City, Utah 84103US

ANDERSEN, DenisePO Box 371608 Montara, California 94037US

GAO, Qi5 Hoagland Place Franklin Park, New Jersey 08823US

Information about Fees